French-based Sanofi sales reached almost €19.8 billion ($20.17 billion) in the first half of the year, up 14.2 per cent on a reported basis. Exchange rate movements had a positive effect of 5.8 percentage points. At constant exchange rates (CER), company sales were up 8.4 per cent. The group’s second-quarter sales growth of 8.1 per cent at CER was driven by allergy medicine Dupixent as well as vaccines and consumer healthcare. Pharma giants gaining big in 2022,illustration photo/ freepik.com Sanofi CEO Paul Hudson said, “Our performance in the second quarter was again marked by higher sales across our key growth drivers and outstanding financial results leading us to upgrade our business earnings per share guidance for the full year.” While Sanofi continues to increase investment in research and development (R&D), Hudsen added that it is confident in the business outlook for the second half and reiterated the commitment to achieve the business operating income … [Read more...] about Pharma giants gaining big in 2022